Xbrane Biopharma ABXbrane Biopharma AB - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

If you are employed by Xbrane Biopharma AB and you wish to licence your ESG rating, please contact us. The dashboard contains a Q&A section about Xbrane Biopharma AB. This webpage displays a zero-cost ESG assessment covering Xbrane Biopharma AB.

Xbrane Biopharma AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 4.0, social score of 8.0 and governance score of 3.2.

SDG Transparency Score for Xbrane Biopharma AB 
Low
0 - 3

5.1

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Xbrane Biopharma AB 
4.0

Environmental

8.0

Social

3.2

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
687Valbiotis SA
5.2
High
687Zeria Pharmaceutical Co Ltd
5.2
High
724Xbrane Biopharma AB
5.1
High
724Catalyst Pharmaceuticals Inc
5.1
High
724Adverum Biotechnologies Inc
5.1
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Xbrane Biopharma AB have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Xbrane Biopharma AB report the average age of the workforce?

LockedSign up for free to unlock

Does Xbrane Biopharma AB reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose cybersecurity risks?

LockedSign up for free to unlock

Does Xbrane Biopharma AB offer flexible work?

LockedSign up for free to unlock

Does Xbrane Biopharma AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Xbrane Biopharma AB conduct supply chain audits?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Xbrane Biopharma AB conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose water use targets?

LockedSign up for free to unlock

Does Xbrane Biopharma AB have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Xbrane Biopharma AB have a product recall in the last two years?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose incidents of discrimination?

LockedSign up for free to unlock

Does Xbrane Biopharma AB allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Xbrane Biopharma AB issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose parental leave metrics?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Xbrane Biopharma AB support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Xbrane Biopharma AB reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Xbrane Biopharma AB involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose its waste policy?

LockedSign up for free to unlock

Does Xbrane Biopharma AB report according to TCFD requirements?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose energy use targets?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Xbrane Biopharma AB have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Xbrane Biopharma AB
These potential risks are based on the size, segment and geographies of the company.

Xbrane Biopharma AB (publ), a biotechnology company, develops, manufactures, and sells biosimilars. The company is developing Xlucane, a ranibizumab biosimilar that is in Phase III clinical trials used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic related retinopathy, and retinal vein occlusion. Its pre-clinical phase products include Xcimzane for rheumatoid arthritis, axial spondylarthrosis, psoriatic arthritis, and psoriasis and crohn diseases; Xoncane for acute lymphocytic leukemia; Spherotide for prostate cancer, breast cancer, endometriosis, and myoma; and Xdivane for melanoma, lung, head and throat, bladder, and urinary tract cancer, as well as for renal cell carcinoma. The company has a strategic biosimilar development partnership with STADA Arzneimittel AG to evaluate development and commercialization collaborations around its Xcimzane and Xdivane preclinical biosimilars. Xbrane Biopharma AB (publ) was founded in 2008 and is headquartered in Solna, Sweden.

Sorry!

Failed to process!